Total Payments
$4,759
2019 Payments
$107.95
Companies
11
Transactions
27
Medicare Patients
2,288
Medicare Billing
$197,152
Payment Breakdown by Category
Consulting$3,150 (66.2%)
Food & Beverage$870.11 (18.3%)
Travel$738.39 (15.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,150 | 1 | 66.2% |
| Food and Beverage | $870.11 | 23 | 18.3% |
| Travel and Lodging | $738.39 | 3 | 15.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $4,314 | 10 | $0 (2018) |
| Amgen Inc. | $225.73 | 2 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $69.36 | 3 | $0 (2017) |
| Mallinckrodt LLC | $41.70 | 3 | $0 (2017) |
| GENZYME CORPORATION | $36.68 | 3 | $0 (2017) |
| EMD Serono, Inc. | $14.39 | 1 | $0 (2017) |
| Mitsubishi Tanabe Pharma America, Inc. | $13.35 | 1 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $11.87 | 1 | $0 (2017) |
| Genentech USA, Inc. | $11.43 | 1 | $0 (2017) |
| Biogen, Inc. | $10.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $107.95 | 1 | Amgen Inc. ($107.95) |
| 2018 | $4,432 | 11 | AbbVie, Inc. ($4,314) |
| 2017 | $218.94 | 15 | Supernus Pharmaceuticals, Inc. ($69.36) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: Neuroscience | ||||||
| 12/12/2018 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| 12/12/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $89.62 | General |
| 12/12/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $31.00 | General |
| 10/20/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $433.31 | General |
| 10/20/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $87.45 | General |
| 10/20/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $77.58 | General |
| 10/20/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $51.66 | General |
| 10/20/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $44.25 | General |
| 10/19/2018 | AbbVie, Inc. | — | Travel and Lodging | In-kind items and services | $215.46 | General |
| 10/19/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $133.50 | General |
| 06/28/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $117.78 | General |
| Category: Neuroscience | ||||||
| 11/06/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $21.49 | General |
| Category: AED | ||||||
| 10/04/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/19/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: AED | ||||||
| 08/23/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/09/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/02/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/12/2017 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 06/14/2017 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Immunology | ||||||
| 06/07/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: AED | ||||||
| 05/19/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/11/2017 | Piramal Imaging Limited | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $9.37 | General |
| Category: Diagnostic Tracer | ||||||
| 04/26/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: NEUROLOGY | ||||||
| 03/29/2017 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 616 | 719 | $245,646 | $53,626 |
| 2022 | 13 | 570 | 644 | $211,543 | $50,075 |
| 2021 | 14 | 663 | 751 | $225,540 | $57,153 |
| 2020 | 13 | 439 | 521 | $144,222 | $36,298 |
Total Patients
2,288
Total Services
2,635
Medicare Billing
$197,152
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 91 | 112 | $53,324 | $11,892 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 97 | 127 | $44,242 | $9,748 | 22.0% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 59 | 60 | $25,722 | $5,271 | 20.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 98 | 111 | $21,627 | $4,278 | 19.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 37 | $11,831 | $3,815 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 37 | 37 | $18,256 | $3,808 | 20.9% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 33 | 33 | $17,682 | $3,543 | 20.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $9,981 | $2,555 | 25.6% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 14 | 14 | $10,678 | $2,212 | 20.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $10,117 | $2,195 | 21.7% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 32 | 32 | $10,324 | $2,028 | 19.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 89 | 109 | $8,424 | $1,621 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 14 | $3,438 | $659.70 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 89 | 108 | $47,808 | $12,640 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 68 | 84 | $26,670 | $6,133 | 23.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 50 | 50 | $26,192 | $5,734 | 21.9% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 62 | 62 | $26,000 | $5,714 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 35 | 35 | $16,735 | $3,460 | 20.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 84 | 88 | $17,022 | $3,437 | 20.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $8,661 | $2,534 | 29.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 28 | $8,344 | $2,513 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $8,928 | $2,190 | 24.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 94 | 112 | $8,511 | $1,804 | 21.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 21 | 21 | $6,593 | $1,401 | 21.3% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2022 | 11 | 11 | $6,959 | $1,359 | 19.5% |
About Dr. Jennifer Grillo, M.D
Dr. Jennifer Grillo, M.D is a Electrodiagnostic Medicine healthcare provider based in Lawrence, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740276658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Grillo, M.D has received a total of $4,759 in payments from pharmaceutical and medical device companies, with $107.95 received in 2019. These payments were reported across 27 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($3,150).
As a Medicare-enrolled provider, Grillo has provided services to 2,288 Medicare beneficiaries, totaling 2,635 services with total Medicare billing of $197,152. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Neurology, Neurology
- Location Lawrence, MA
- Active Since 09/26/2005
- Last Updated 06/12/2019
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1740276658
Products in Payments
- Aimovig (Biological) $225.73
- TROKENDI XR (Drug) $69.36
- ACTHAR (Biological) $41.70
- LEMTRADA (Drug) $25.78
- Rebif (Biological) $14.39
- Radicava (Drug) $13.35
- ONZETRA Xsail (Drug) $11.87
- OCREVUS (Biological) $11.43
- AUBAGIO (Drug) $10.90
- TYSABRI (Biological) $10.79
- NEURACEQ (Drug) $9.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.